Minesapride = placebo to reduce constipation in patients with irritable bowel syndrome with predominant constipation

Clinical Question

Is minesapride more effective than placebo to increase spontaneous bowel movements in patients with irritable bowel syndrome with predominant constipation?

Bottom line

Minesapride, an investigational treatment for irritable bowel syndrome with predominant constipation (IBS-C), is no more effective than placebo in affecting the composite outcome of reducing abdominal pain and increasing spontaneous bowel movements in patients with severe symptoms. 1b-

Study design: Randomized controlled trial (double-blinded)

Funding: Industry

Setting: Outpatient (specialty)

Reviewer

Allen F. Shaughnessy, PharmD, MMedEd
Professor of Family Medicine
Tufts University
Boston, MA


Discuss this POEM


Comments

Anonymous

minesapride

a patient of mine with IBS/constipation, sought out this preparation while in USA, and found irritating diarrhoea, with no relief of the pain. Our trial of 1 indicates failure. I suppose in the target endpoint, he would be a success, as his bowel movements were increased, but his conclusion: he would not tolerate again.

Alan Kenneth Macklem

IBS

The treatment involves things other than medications